← Back to Search

Patient Nudge for Cancer (SPP2 Trial)

N/A
Waitlist Available
Led By Samuel Takvorian, MD
Research Sponsored by Abramson Cancer Center of the University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 months of the index visit
Awards & highlights

SPP2 Trial Summary

This study is evaluating whether nudges to clinicians and nudges to patients can increase the frequency and timeliness of serious illness conversations.

SPP2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 months of the index visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 6 months of the index visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
SIC Documentation - High Risk Patients
Secondary outcome measures
Aggressive End-Of-Life Care - Decedent High Risk Patients
Palliative Care Referral - High Risk Patients
SIC Documentation - All Patients

SPP2 Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Patient NudgeExperimental Treatment1 Intervention
Patients receive a nudge consisting of a normalizing message prompting patients to complete an electronic questionnaire designed to prime patients towards having an SIC.
Group II: Clinician and Patient NudgeExperimental Treatment2 Interventions
Both strategies described above will be used.
Group III: Clinician NudgeExperimental Treatment1 Intervention
Clinicians receive a nudge consisting of targeted text messages identifying patients at high risk of predicted 6-month mortality based on a validated machine learning prognostic algorithm as well as performance feedback compared to peers.
Group IV: Usual CareActive Control1 Intervention
Clinicians and patients will receive no further interventions beyond usual practice. Usual care for clinicians includes a nudge consisting of targeted text messages identifying patients at high risk of predicted 6-month mortality based on a validated machine learning prognostic algorithm.

Find a Location

Who is running the clinical trial?

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
100,484 Total Patients Enrolled
Abramson Cancer Center at Penn MedicineLead Sponsor
387 Previous Clinical Trials
141,084 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,928,542 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
2021. "Effect of Behavioral Nudges on Serious Illness Conversation Documentation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04867850.
~1287 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top